Ascendo Biotechnology Co., Ltd.
Clinical trials sponsored by Ascendo Biotechnology Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced cancer: first human trial of ASD141 begins Results expected Dec 2026 (estimated)